Vertex Pharma (VRTX) Tops Q2 EPS by 25c, Beats on Revenue; Offers FY25 Revenue Guidance
Go back to Vertex Pharma (VRTX) Tops Q2 EPS by 25c, Beats on Revenue; Offers FY25 Revenue Guidance| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 508.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $508.34 | 52 Week High | $134.71 | |||
| Open | $508.34 | 52 Week Low | $73.31 | |||
| Day High | $508.34 | P/E | N/A | |||
| Day Low | $508.34 | EPS | $-1.98 | |||
| Volume | 717 | |||||
